June 24, 2026
An integrative, physician-designed approach to female fertility — addressing the upstream metabolic, hormonal, autoimmune, and lifestyle drivers, working alongside your reproductive medicine team.
What it targets: The upstream physiology of female fertility — ovarian reserve, oocyte quality, mitochondrial bioenergetics, hormonal balance, thyroid and autoimmune status, metabolic health, and the lifestyle layer that influences all of these.
Who it’s for: Women planning conception, trying without success, in IVF/ICSI prep, with PCOS, low AMH, recurrent loss, or autoimmune-related fertility concerns. Works alongside your reproductive endocrinologist.
How it works: Physician-supervised preconception workup, metabolic and mitochondrial optimisation (the core driver of oocyte quality), thyroid and autoimmune correction where indicated, micronutrient repletion, and — in selected cases — PRP Ovarian Rejuvenation or autologous cell therapy as ALIV’s regenerative offerings.
What to expect: Hormonal regularity, metabolic markers, energy, and cycle quality often shift in early and building phases. For women in IVF cycles, biology is optimised before stimulation. ALIV does not guarantee conception or pregnancy.
Female fertility in India is changing. Primary infertility affects roughly 8.9% of urban women in community studies. Many of our clients arrive researching female fertility treatment, PCOS treatment, low AMH treatment, IVF preparation, how to improve egg quality, endometriosis-related infertility, or preconception care in India — and want an integrative approach alongside their reproductive endocrinologist.
Fertility is the integrated output of mitochondrial bioenergetics, thyroid, metabolic health, autoimmune balance, oxidative stress, nutrition, sleep, stress, and environmental exposures. ALIV addresses this upstream layer alongside your reproductive medicine team.
This protocol was built for you if:
Important: This protocol works alongside reproductive medicine, not instead of it. ALIV is not a fertility specialist centre. Your reproductive endocrinologist remains the primary clinician.
Female fertility is the integrated output of multiple systems: HPO-axis function, mitochondrial bioenergetics, thyroid, metabolic health, autoimmune balance, and lifestyle. The ALIV approach addresses these in 7 individualised layers — not every client needs every layer. Your protocol is built around your biology, stage, and goals: a 32-year-old with PCOS has a different protocol from a 41-year-old preparing for IVF or a 35-year-old with endometriosis-related infertility.
A workup deeper than standard fertility evaluation: full thyroid panel with TPO antibodies, AMH, FSH, LH, oestradiol, progesterone, prolactin, fasting insulin/HOMA-IR, HbA1c, micronutrient and inflammatory markers. Baseline drives which downstream layers apply.
Oocyte quality is fundamentally a mitochondrial story. Each oocyte carries the highest mitochondrial density of any cell, and function declines with age — driving age-related decline in oocyte quality. CoQ10/Ubiquinol is the lead; RCT evidence shows pre-IVF supplementation improves oocyte count and embryo quality in women with diminished reserve. For age 38+ or significant mitochondrial decline, SS-31 and NAD+ support can be added. PCOS-specific: inositols (myo + D-chiro), ALCAR, NAC. Calibrated to age, AMH, and PCOS status — selected per workup, not given as a fixed stack.
Suboptimal thyroid function — even within 'normal' range — affects ovulation, oocyte quality, implantation, and miscarriage risk. Coordinates with the Hashimoto's Thyroiditis Protocol. Thyroid antibodies independently affect fertility. For clients with Hashimoto's, lupus, antiphospholipid syndrome, or other autoimmune contributors, Thymosin Alpha-1 can be considered as an immune-balancing adjunct alongside the Autoimmune Support Protocol. Activated only when antibodies, autoimmune markers, or history indicate need.
Endometriosis affects an estimated 6-10% of reproductive-age women and is one of the most under-diagnosed contributors to fertility difficulty. For clients with diagnosed or strongly suspected endometriosis, this layer adds anti-inflammatory and tissue-modulating support alongside specialist gynaecology. GHK-Cu (anti-inflammatory, tissue-remodeling copper peptide) and BPC-157 (anti-inflammatory, reparative) are considered case-by-case as investigational adjuncts. ALIV does not replace laparoscopic management or hormonal suppression. Activated only with an endometriosis indication.
Beyond CoQ10: methylated folate (5-MTHF), Vitamin D, Omega-3, methylated B-complex, NAC, iron where indicated. The 3-6-month preconception window shapes the maturing oocyte cohort. Targeted to your bloodwork and dietary gaps — not blanket supplementation.
ALIV offers PRP Ovarian Rejuvenation for selected clients with diminished ovarian reserve, POI, or prior poor IVF response. Pilot studies report promising AMH and follicle count effects; controlled trial data smaller and less consistent. Case-by-case with reproductive endocrinology.
For DOR or POI cases where PRP alone is insufficient, ALIV's autologous cell therapy pathway can be considered. Investigational; reserved for selected clients. Evidence early; outcomes not guaranteed.
Female fertility outcomes are influenced by many factors — age, structural anatomy, ovarian reserve genetics — that are not modifiable. The protocol optimises everything that is.
Phase | What You May Notice |
Early phase | Energy, sleep, and cycle regularity improve. Metabolic markers move. Mitochondrial and micronutrient repletion underway. |
Building phase | Thyroid and hormonal markers stabilise. Biology shaped for the oocyte-maturation window. |
Sustained phase | Optimised baseline for conception or IVF. PRP or cell therapy considered only when indicated. |
Fertility outcomes are influenced by age, baseline reproductive biology, structural factors, partner factors, and chance. ALIV does not guarantee conception, IVF success, or pregnancy.
Before starting, your ALIV team runs the diagnostic assessment, reviews your gynaecology and reproductive medicine input, and — with your permission — coordinates with your fertility specialist. Contraindications detailed in the FAQ below.
Lifestyle is one of the most evidence-supported fertility intervention categories.
Nutrition, weight, sleep, stress, environment: Mediterranean-style patterns have the strongest fertility evidence. Weight either direction from optimal affects fertility. Sleep matters for reproductive hormones. Stress reduction improves IVF outcomes. Avoid endocrine disruptors (plastics, BPA, certain personal-care products).
Smoking, alcohol, movement: Smoking is one of the strongest negative factors — cessation is high-leverage. Alcohol reduces fertility and pregnancy outcomes. Movement is essential; excessive endurance training during preconception is counterproductive.
Will this replace IVF or my reproductive endocrinologist?
No. IVF, IUI, surgical evaluation, and other reproductive medicine are delivered by your fertility specialist. ALIV provides the integrative optimisation layer alongside.
Can PRP Ovarian Rejuvenation help me?
Evidence is mixed. Pilot studies have reported promising effects on AMH and follicle counts; controlled trial data has been smaller and less consistent. Considered only when clinically indicated, with reproductive endocrinology coordination.
Can I improve my AMH or egg quality?
AMH largely reflects ovarian reserve, principally determined by age and genetics, and typically doesn't increase substantially with intervention. Oocyte quality — distinct from quantity — is influenced by mitochondrial function, oxidative stress, and nutrition over the 3-6-month maturation window. CoQ10 has the strongest evidence for oocyte quality improvement.
How long should I do this before trying to conceive?
Generally 3-6 months minimum — the window during which the maturing oocyte cohort is shaped by your internal environment. For IVF prep, 3 months is standard.
Can PCOS be cured?
PCOS is chronic and not 'cured' in the conventional sense. Achievable for many: restoration of ovulatory cycles, improvement in metabolic markers, symptom resolution (acne, hirsutism, cycle regularity), and meaningful improvement in fertility outcomes. Some achieve apparent remission on labs; most manage long-term within an optimised metabolic envelope. Mitochondrial work plus lifestyle is the highest-leverage approach.
I have PCOS — what does this protocol do for me?
PCOS-specific elements: metabolic and mitochondrial optimisation (inositols, CoQ10), thyroid coordination, lifestyle work. Goal: restoring ovulatory function and improving the metabolic environment for conception.
I’m over 40. Is it too late?
Female fertility declines with age, particularly after 38, and no protocol reverses that. The protocol optimises everything within your modifiable range. Pursuing reproductive medicine quickly is often the right call.
Who should NOT do this protocol?
Active gynaecological conditions requiring surgical management as primary care; established pregnancy without reproductive endocrinology coordination; clients seeking to bypass appropriate fertility specialist care.
Female fertility is personal and time-sensitive. The right approach respects that — alongside reproductive medicine.
To find out if the Female Fertility Support Protocol is right for you, speak with our medical team:
Or book a consultation through alivtherapy.in.
1. Ben-Meir A, Burstein E, Borrego-Alvarez A, et al. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell. 2015;14(5):887-895. PMID: 26111777
2. Xu Y, Nisenblat V, Lu C, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2018;16(1):29. PMID: 29587861
3. Bharali MD, Rajendran R, Goswami J, Singal K, Rajendran V. Prevalence of polycystic ovarian syndrome in India: a systematic review and meta-analysis. Cureus. 2022;14(12):e32351. PMID: 36628015
4. Sfakianoudis K, Simopoulou M, Grigoriadis S, et al. Reactivating ovarian function through autologous platelet-rich plasma intraovarian infusion: pilot data on premature ovarian insufficiency, perimenopausal, menopausal, and poor responder women. J Clin Med. 2020;9(6):1809. PMID: 32532000
5. Karayiannis D, Kontogianni MD, Mendorou C, Mastrominas M, Yiannakouris N. Adherence to the Mediterranean diet and IVF success rate among non-obese women attempting fertility. Hum Reprod. 2018;33(3):494-502. PMID: 29452380
Disclaimer
The information on this page is for educational purposes only and is not intended as medical advice. ALIV therapies are not intended to diagnose, treat, cure, or prevent any disease, including infertility. This protocol is integrative supportive care provided alongside — not as a replacement for — specialist reproductive medicine, gynaecology, or IVF/ICSI services. Outcomes vary significantly between individuals; ALIV does not guarantee conception, pregnancy, live birth, or any specific fertility outcome. PRP Ovarian Rejuvenation Therapy and autologous cell therapy are investigational regenerative options; evidence is early-to-mixed and they are not FDA-approved. Both are reserved for selected cases after physician assessment and reproductive endocrinology coordination. Informed consent is essential. Some supplementation and lifestyle interventions are subject to your treating fertility specialist’s direction during active IVF cycles. Please consult a qualified healthcare professional before starting any therapy programme.